A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 15
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MF
Long Form : methotrexate and 5-fluorouracil
No. Year Title Co-occurring Abbreviation
2010 Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis. AGC, CI, DIC
2005 Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer. RR
2004 Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. CI, CMF, HRs, OS, RFS
2003 Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. EORTC, OS, QOL, TTP, WHO
2002 C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer. RR, WHO
2002 The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. ER, OS
2001 Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer. CMF, DFS, ER, IBTR, NSABP, RFS, TAM
2001 Timing of quality of life (QoL) assessments as a source of error in oncological trials. QOL
2000 Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. mdm2
10  2000 Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group. EORTC, QOL
11  1999 Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group. OS, TTP
12  1995 Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics. Cancer and Leukemia Group B. ---
13  1994 Indications for breast-preserving surgery and adjuvant therapy in early breast cancer. ER, NASBP
14  1989 Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. NSABP
15  1989 [Randomized multicenter trial of sequential methotrexate and 5-fluorouracil versus 5-fluorouracil alone in advanced gastric cancer]. ---